| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |